Archives

STAT+: Is the White House’s deal with pharma on GLP-1 drugs a game changer? ​STAT+: Is the White House’s deal with pharma on GLP-1 drugs a game changer?  

President Trump last week hailed his deal with pharma companies to cut the price of blockbuster weight loss drugs as a major win for his administration and for increasing drug affordability. The question is how big of a difference the agreement will make for patients. The deal is expected to significantly expand access to GLP-1 Read More

Gordon Ramsay calls Ozempic restaurant menus ‘absolute bulls—‘ in profanity-filled rant​Gordon Ramsay calls Ozempic restaurant menus ‘absolute bulls—‘ in profanity-filled rant 

Gordon Ramsay didn’t hold back when speaking out on whether he would alter his restaurants’ menus to cater to diners who are taking popular weight loss drugs including Ozempic and Mounjaro. During a recent interview with The Sunday Times, the 59-year-old celebrity chef was asked whether he would create special, smaller-portion menus for patrons using Read More

America’s obesity crisis meets the Ozempic boom as data reveals GLP-1 hot spots​America’s obesity crisis meets the Ozempic boom as data reveals GLP-1 hot spots 

With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher — a trend already spreading unevenly across the U.S., with some states seeing greater uptick than others. Based on insurance claims data from Purple Lab, a Read More

Novel GLP-1 Drug on Attack Path Against Very High Triglycerides​Novel GLP-1 Drug on Attack Path Against Very High Triglycerides 

(MedPage Today) — NEW ORLEANS — An investigational triple-receptor agonist made some headway in patients with severe hypertriglyceridemia, a phase II study showed. One Chinese cohort had triglycerides slashed from around 800 mg/dL at baseline… ​ (MedPage Today) — NEW ORLEANS — An investigational triple-receptor agonist made some headway in patients with severe hypertriglyceridemia, a Read More

GLP-1 Use Prior to Pregnancy Tied to Lower Gestational Diabetes Risk​GLP-1 Use Prior to Pregnancy Tied to Lower Gestational Diabetes Risk 

(MedPage Today) — ATLANTA — Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of gestational diabetes but not pre-eclampsia during pregnancy, according to a small retrospective cohort study… ​ (MedPage Today) — ATLANTA — Women who had been taking GLP-1 receptor agonist medications prior to becoming Read More

Davina McCall reveals she has undergone surgery for breast cancer​Davina McCall reveals she has undergone surgery for breast cancer 

Presenter says she is ‘in a much more positive place’ after having lumpectomy and catching cancer earlyDavina McCall has revealed she has undergone surgery for breast cancer and urged others to “get checked”.In a video posted to Instagram, the presenter said she was “very angry” when she found out about the cancer, but felt in a “much more positive place” after a lumpectomy. Continue reading…

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model​HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model 

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. The regimen, which pre-treats the tumor before delivering targeted alpha-radioimmunotherapy, resulted in durable major responses—including histologic cures—with minimal toxicities, paving the way for a safer and more effective treatment option for breast cancer patients.